Higher protein for intensive care patients with kidney failure
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares giving a higher amount of protein to a standard amount in ICU patients with sudden kidney failure who need dialysis. The goal is to see if more protein helps recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the intensive care unit with a sudden kidney injury and need dialysis
- You are able to get enough nutrition (through a feeding tube or by mouth) within the first week in the ICU
- You or your family can give permission to join
- You do not have long-term kidney failure, have not had a kidney transplant, and are not pregnant or breastfeeding
- You do not have severe liver problems, severe diabetes complications, or burns
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two different levels of dosing for continuous dialysis (CRRT) in patients with severe acute kidney injury in the ICU. It aims to find out which dose might be better for recovery.
This study tests whether different amounts of protein in tube feeding or IV nutrition affect kidney recovery in patients admitted to the intensive care unit (ICU) with kidney injury. The goal is to find the best protein level to help kidneys heal while patients are critically ill.
This trial tests whether a high-protein diet or standard protein diet is better for critically ill patients who are at risk for refeeding syndrome (dangerous shifts in fluids and minerals when starting nutrition after starvation). The goal is to see which type of nutrition helps recovery.
This study compares two different doses of continuous kidney replacement therapy (CRRT, a type of dialysis) for patients in the intensive care unit with acute kidney injury. It aims to find out if a lower dose is as safe and effective as the standard dose.
This trial compares a lower dose versus a standard dose of continuous kidney replacement therapy (CRRT) for critically ill patients with acute kidney injury (AKI — sudden kidney failure). It aims to see if lower doses are safe and effective.
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
Hear when a new Continuous Renal Replacement Therapy (CRRT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.